Member Info for NathanR999

*if p3 hct gets wider approval by euro and us medicines agencies.

This is the key maybe across the board for challenge trials. Doing a big p3 is expensive, needs large recruitment and if infection isn't prevalent at the time the data signal for performance could be unclear or misleading as you don't know exact numbers of exposures. With a large say +200 cohort challenge with defined infection it would give much clearer efficacy read out. The safety aspect could be smaller and still in community-broad safety would already be established in early phases anyway. We will need a bigger boat if t

This is the key maybe across the board for challenge trials. Doing a big p3 is expensive, needs large recruitment and if infection isn't prevalent at the time the data signal for performance could be unclear or misleading as you don't know exact numbers of exposur

For arguments sake say 20m as minimal with ref to prev big trials. Leaves 10 to 15m to be disclosed maybe by next financial rns update. Think 2025 is secure in my mind.

We had the rsv 13m, lab 3.2 m. Bordetella unknown value but big trial so let's fornarguments

Should read 1/3 of patients UNusable!!

The p2b was done with 45 patients with 36 getting adequate dose. So c1/3rd of patients usable. If p3 is a quantum larger it could take several bookings of comparable flu trial (flu p3 is usually a field trial to get the scale needed) will be definately interesting to see numbers on this once full agreement is thrashed out.

This vaccine has been done by a Southampton uni/NHS group by hct before as part of phase 2b. I think they used a hotel for subjects rather than a specialist suite. Interesting that p3 being done at hvivo once terms are sorted. Wonder if they expand suite to second floor? Big study equals big fee?

Lot of cross Swedish peeps on $seye hashing on X. Last lot was sold for tax purposes as an excuse. Nothing so far this time and sale date was just before closed period on Nasdaq nordic. Numbers due 18 Feb. Mcap still 140m gbp. Squeaky bum time. For balance I think our numbers will just be ok not stellar only on basis car market seems woeful at moment so may affect production numbers. Some dms wins in the next month would go down well.

Now we know why this is out today. MK, ceo at Smarteye sold 50k shares. Ive buying,krantz selling maybe nothing ;-)

New note

https://www.redeye.se/research/1068291/smart-eye-preview-q424-sequential-automotive-growth-expected?utm_source=note&utm_medium=email¬ificationId=c8f22ad6-a905-4f81-99e1-da985740c5e7

how much of salary do risk buying shares?

how much of your salary have you risked buying see specifically?

what gives a gob****e like you the agency to direct others capital?

is the bloke allowed to use his salary to feed his family,pay mortgage, run a diversified portfolio (ie invest in non see shares)

Https://www.hcplive.com/view/wang-appropriate-ferritin-threshold-cost-effective-iron-deficiency-screening?s=09

Bringing in more patients for potential iron replacement. Ferric citrate and gastro disturbance well know and we know Ferracru is better tolerated. Early days but if you add 2 and 2.....

Small placing announced to pay license fee for the Iris recognition licence.

Are you an idiot? Smarteye have a massive booth. Based on comparative sizes you some of the large global infectious disease conferences my employer attends their booth,attendance and travel costs could hit 300k usd or more. They will like need to fit 60k cars to cover that. Or use their shareholders funds ftom their last placing. Suite type presence esp if other exposure on the main floor is really cost effective. Seriously there is a reason most people should by a tracker....

Not a scientist then and under stand causation and correlation. Gotcha. It's alright there maybe remedial schools you can attend to catch up.#slow learners club

Fat fingers. Private suite for detailed nda led offerings. I am an investor here and pretty happy with CES exposure here. Can't please some people.

What do you think they have seen that they would be unhappy with? You must have some ideas? On booth with valeo tier 1, on booth with melco tier 1, magna also, qnx blackberry on booth with them. Privat

Https://bit.ly/40oyNfS

Pmg liked this on linkedin. Chiplets with designated tasks. Wonder if we will have occular npu in this. This is our differential vs all other dms players.

Https://x.com/MarKluft/status/1876714507684180258?s=19

Make of that what you will.